SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $558,240 | -25.4% | 160,876 | 0.0% | 0.00% | – |
Q2 2023 | $748,073 | +11.0% | 160,876 | +10.2% | 0.00% | – |
Q1 2023 | $674,243 | -42.1% | 145,940 | +1.2% | 0.00% | – |
Q4 2022 | $1,164,708 | +59.8% | 144,147 | +9.9% | 0.00% | – |
Q3 2022 | $729,000 | +16.6% | 131,205 | +9.5% | 0.00% | – |
Q2 2022 | $625,000 | -36.5% | 119,783 | +0.1% | 0.00% | – |
Q1 2022 | $984,000 | -39.7% | 119,667 | +9.2% | 0.00% | – |
Q4 2021 | $1,631,000 | -20.0% | 109,549 | +1.6% | 0.00% | -100.0% |
Q3 2021 | $2,038,000 | +5.4% | 107,873 | +3.7% | 0.00% | 0.0% |
Q2 2021 | $1,934,000 | +4.4% | 103,998 | +27.8% | 0.00% | 0.0% |
Q1 2021 | $1,853,000 | +21.5% | 81,398 | +15.9% | 0.00% | 0.0% |
Q4 2020 | $1,525,000 | +130.4% | 70,225 | +6.6% | 0.00% | – |
Q3 2020 | $662,000 | +76.5% | 65,859 | +36.5% | 0.00% | – |
Q2 2020 | $375,000 | +62.3% | 48,231 | +113.5% | 0.00% | – |
Q1 2020 | $231,000 | -7.2% | 22,592 | 0.0% | 0.00% | – |
Q4 2019 | $249,000 | +20.9% | 22,592 | 0.0% | 0.00% | – |
Q3 2019 | $206,000 | -20.2% | 22,592 | 0.0% | 0.00% | – |
Q2 2019 | $258,000 | +72.0% | 22,592 | +72.3% | 0.00% | – |
Q1 2019 | $150,000 | +26.1% | 13,110 | 0.0% | 0.00% | – |
Q4 2018 | $119,000 | – | 13,110 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $5,814,259 | 1.78% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 5,883,693 | $20,416,415 | 1.10% |
Kynam Capital Management, LP | 1,552,675 | $5,387,782 | 0.88% |
Parkman Healthcare Partners LLC | 1,182,168 | $4,102,123 | 0.75% |
Rubric Capital Management LP | 3,344,810 | $11,606,491 | 0.44% |
BVF INC/IL | 3,347,946 | $11,617,373 | 0.31% |
DAFNA Capital Management LLC | 283,079 | $982,284 | 0.31% |
SECTORAL ASSET MANAGEMENT INC | 432,339 | $1,500,216 | 0.29% |
Eversept Partners, LP | 769,638 | $2,670,644 | 0.23% |
Frazier Life Sciences Management, L.P. | 780,000 | $2,706,600 | 0.18% |